Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.56 is 50% above its 5-year average of -1.13, near the high end of its 5-year range (-1.80–-0.56).
36.72% above its 12-month average of -0.89.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.56
EARNINGS PER SHARE (EPS) AVG TTM
-0.89
EARNINGS PER SHARE (EPS) AVG 3Y
-1.18
EARNINGS PER SHARE (EPS) AVG 5Y
-1.13
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.72%
CURRENT VS 3Y AVG
+52.44%
CURRENT VS 5Y AVG
+50.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Sight Sciences, Inc.
Market Cap
$465.75M
Earnings Per Share (EPS)
-0.56
TTM Avg
-0.89
3Y Avg
-1.18
5Y Avg
-1.13
Market Cap
$468.55M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$469.66M
Earnings Per Share (EPS)
-0.31
TTM Avg
-0.44
3Y Avg
-0.93
5Y Avg
-0.65
Market Cap
$469.71M
Earnings Per Share (EPS)
0.16
TTM Avg
-2.02
3Y Avg
-3.99
5Y Avg
-3.80
Market Cap
$471.56M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$474.32M
Earnings Per Share (EPS)
-1.99
TTM Avg
-0.88
3Y Avg
-1.91
5Y Avg
-1.95
Market Cap
$447.43M
Earnings Per Share (EPS)
-2.45
TTM Avg
-1.70
3Y Avg
-1.35
5Y Avg
-1.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $465.75M | -0.56 | -0.89 | -1.18 | -1.13 |
| Cerus Corporation (CERS)vs › | $468.55M | -0.04 | -0.10 | -0.16 | -0.22 |
| Kamada Ltd. (KMDA)vs › | $469.86M | 0.38 | 0.32 | 0.19 | 0.19 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.66M | -0.31 | -0.44 | -0.93 | -0.65 |
| Arvinas, Inc. (ARVN)vs › | $469.71M | 0.16 | -2.02 | -3.99 | -3.80 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $471.56M | -1.73 | -1.90 | -1.16 | -1.16 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $474.32M | -1.99 | -0.88 | -1.91 | -1.95 |
| NRC Health (NRC)vs › | $454.45M | 0.25 | 0.79 | 1.03 | 1.18 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | -2.45 | -1.70 | -1.35 | -1.20 |
| Ovid Therapeutics Inc. (OVID)vs › | $446.87M | -0.48 | -0.30 | -0.53 | -0.29 |
Trailing EPS (TTM)
$-0.56
Forward EPS (Est.)
$-0.64
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.74 |
| 2024-12-31 | -1.03 |
| 2023-12-31 | -1.14 |
| 2022-12-31 | -1.80 |
| 2021-12-31 | -1.33 |
| 2020-12-31 | -0.74 |
| 2018-12-31 | -0.44 |
